Introduction
Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy-specific liver disease that usually emerges in the last trimester of pregnancy with generalized pruritus of the skin and resolves itself spontaneously after birth. Although it has a minimal risk for the mother, there are serious risks for the fetus. It is diagnosed based on clinical findings, elevation of serum bile acids, and increased liver transaminases. There are differences in its prevalence in different regions and countries. It is seen in the United States, England, and Sweden at low rates such as 0.01%, 0.07%, and 2.8%, respectively, and in Chile and Bolivia with the highest prevalence of 15% (1) . It has been reported that there has been a decrease in the prevalence of these countries in recent years (2, 3) .
Although the exact etiology is unknown, it is estimated that racial, genetic, hormonal, nutritional, and environmental factors play a role (4) . Itching and liver function test abnormalities improve after birth completely. One of the most sensitive tests in the diagnosis of ICP is increase in total serum bile acids. It has been reported that this increase was in parallel with an increase in fetal risks. Fetal risks include preterm birth, low Apgar score, fetal distress, sudden intrauterine fetal death, and meconiumstained amniotic fluid. Despite the use of various agents, ursodeoxycholic acid (UDCA) is the most effective agent in the treatment.
There is no standard method for the treatment and follow-up for ICP. Close monitoring of these patients is recommended in terms of both maternal and fetal risks. In our study, we retrospectively evaluated pregnant women who were treated at our hospital with the diagnosis of ICP over the last 5 years.
Materials and methods
The study population was composed of 150 patients hospitalized and treated in the last 5 years with the diagnosis of ICP at our hospital. The patient files were accessed by the ICD-10 computer recording system and reviewed retrospectively. The study was approved by the hospital ethics committee. The patients' liver and biliary tract imaging in terms of organic pathologies, hepatitis B and hepatitis C serology for viral hepatitis, coagulation parameters, and complete blood count were recorded in the form of case information. ICP usually arises in the last trimester, and in particular in weeks 32 and 33 (5) . We divided the patients with a diagnosis of ICP into two groups according to weeks at diagnosis. Early-onset (before 32 weeks) patients formed group A (n = 49) and late-onset (after 32 weeks) patients formed group B (n = 101). In addition, patients were divided into two groups according to the number of pregnancies. The patients with gravida one formed group I (n = 63), and those with gravida two or more formed group II (n = 87). These groups were compared in terms of age, gravida, transaminases, coagulation parameters, complete blood count, cholestasis diagnostic weeks, period between diagnosis and delivery, gestational weeks, and fetal weight.
The data were analyzed using SPSS 16.0 (SPSS Inc., Chicago, IL, USA). Student's t-test and the chi-square test were used to compare the groups. P < 0.05 was considered significant.
Results
The mean age, mean gravida, and mean week of diagnosis of the 150 patients diagnosed with ICP were 28.1 ± 6.2 years, 2.2 ± 1.6, and 31.5 ± 5.8 weeks, respectively. The mean gestational age at delivery, mean time passing until delivery, and mean birth weight were 36.7 ± 2.0 weeks, 4.8 ± 6.3 weeks, and 3070.0 ± 533.9 g, respectively. The laboratory tests averages were: alkaline phosphatase, 217.9 ± 87.0 IU; aspartate aminotransferase, 97.6 ± 71.8 IU; alanine aminotransferase, 158.6 ± 137.9 IU; prothrombin time, 12.9 ± 3.3 s; international normalized ratio, 1.00 ± 0.32; partial thromboplastin time, 29.1 ± 4.6 s, white blood cell count, 10,204 ± 2489.8, hemoglobin, 11.8 ± 1.3 g/dL, hematocrit, 35.2 ± 3.7%, and platelet count, 236.6 ± 75.5 ( Table 1) .
The numbers of deliveries before the 37th pregnancy week (premature) and after the 37th weeks were 52 (34.6%) and 98 (65.3%), respectively. Cases of vaginal delivery and cesarean section were 37 (24.6%) and 113 (75.3%), respectively. There were 6 cases of twin pregnancy (4%), and 1 case (0.6%) of IVF pregnancy. The mean ages of group I and group II were 24.8 ± 5.1 and 30.5 ± 5.8 years, respectively and there was a significant difference between the two groups in terms of the mean age (P = 0.001). Accordingly, patients in group I were younger. There was no significant difference between the two groups in terms of cholestasis diagnosis week, gestational weeks at delivery, period passing until the delivery, fetal weight, alkaline phosphatase, transaminases, or complete blood count and coagulation tests ( Table 2) .
The mean gestational week at diagnosis in group A and group B was 26.07 ± 6.9 and 34.72 ± 2.0 respectively. In group A (early-onset, before 32 weeks) and group B (late-onset, after 32 weeks) the mean periods passing until delivery were 10.1 ± 7.5 and 2.4 ± 3.8 weeks, respectively, and the mean fetal weights were 2924.3 ± 574.5 g and 3135.6 ± 504.1 g, respectively. There was a significant difference between the two groups in terms of the period passing until delivery and fetal weights (P = 0.001, P = 0.035). The gestational weeks at delivery were 36.3 ± 2.6 and 36.8 ± 1.6 weeks, respectively, and there was no difference in this respect between the two groups (P = 0.166). Accordingly, although mean weeks at delivery was the same in both groups, the period passing until delivery was longer in Group A and fetal weights were lower. There was no significant difference between the two groups in terms of age, alkaline phosphatase, transaminases, or complete blood count and coagulation tests (Table 3) .
When the distribution of the months in which the patients were diagnosed was examined, the most common month was March with 27 (18%) patients, and April was the second most common month, with 21 (14%) patients. When the distribution according to the seasons was examined, spring was the most common season in which the patients were diagnosed, with 60 (40%) patients, and the second season was winter, with 44 (29.3%) patients.
Discussion
ICP is a liver disease that is the most common cause of jaundice in pregnant women after viral hepatitis. It has been reported that there are serious fetal risks and minimal maternal risks. Despite the maternal risks being minimal, it has been stated that these patients have a predisposition to certain other diseases. In a study conducted recently on the examination of the diseases diagnosed over long-term periods in patients with cholestasis, hepatobiliary diseases, breast cancer, and hypothyroidism were more common and hypertension, cholesterolosis, and cardiac arrhythmia were seen to a lesser degree in these patients (6) . When the week of diagnosis of the patients was evaluated, despite the fact that there were patients who were diagnosed during the first trimester, in general, they were diagnosed with ICP at average of the third trimester, consistent with the literature. In the study conducted by Kenyon et al. on 70 patients with cholestasis, the initiation of itching, week of diagnosis, cesarean rate, and delivery rate before the 37th week were found to be 30 weeks, 33.7 weeks, 36%, and 17%, respectively, while there was no intrauterine fetal loss and 14% of infants were sent to the neonatal intensive care unit after birth (5). In our study, diagnosis of ICP was performed at a mean of 31.5 weeks, and the delivery rate before the 37th week and the cesarean rate were 34.6% and 75.3%, respectively. According to our evaluation, the increase in cesarean rate is due to the patients undergoing repeated cesarean sections. In parallel with our study, the preterm delivery rate has been reported as 36%-38 % in the literature (7, 8) .
Increase in maternal serum bile acids is a significant predictor. There is a correlation between serum bile acids and perinatal outcomes. It has been reported that when maternal serum levels were under 40 µmol/L, perinatal outcomes were good, and when they were above 40 µmol/L, the incidence of intrauterine mortality increased (9, 10) . Sudden intrauterine fetal loss rates in ICP were reported to be 7%, and 90% of these losses happened after the 37th gestational week (11) . In our study, the low rate of fetal loss of 1/150 (0.6%) can be related with mean delivery week of our patients being 36.7 weeks. UDCA is started as a routine in our hospital for the patients with the diagnosis of ICP. UDCA is selected as the first choice due to its improvement of the maternal symptoms, acceleration of bile transport from placental trophoblasts, and the absence of a negative impact on the mother and fetus. Although it is highly effective in healing the maternal symptoms and reducing the transaminases, the positive impact on the results of fetal healing is not clear. It was reported in the metaanalysis of nine randomized controlled trials conducted recently that UDCA reduced preterm birth, fetal distress, respiratory distress syndrome, and the need for neonatal care (12) . Because no other treatment was received other than UDCA, the low fetal loss rate in our study is controversial as it is difficult to discern whether it was caused by UDCA treatment or not. Many factors are culpable in the etiology of ICP. At a basic level, there are genetic, hormonal, nutritional, and environmental factors. It has been determined that ICP showed seasonal changes, and this was seen especially during the winter months. The reason for this was failure to obtain sufficient diet and selenium during the winter (13) . Selenium plays a role in the detoxification of the liver as a cofactor of glutathione peroxidase, and bile secretion and formation are impaired in the event of its deficiency (14, 15) . In our study, when the time of diagnosis of ICP is examined, it is noteworthy that the spring and winter seasons are the most common seasons. Estrogen and progesterone have been considered among hormonal factors. The findings such as emergence in the second and third trimesters, being more common in twin pregnancies, spontaneous disappearance after birth, and reemergence of cholestasis with oral contraceptives in patients who had ICP support the possibility that hormonal mechanisms play an important role in the etiology (16) . It is known that, although there was no difference with normal pregnancies in terms of high estrogen and progesterone, metabolites in the liver impair the expression of the canalicular protein providing transport of bile acids in patients genetically predisposed (17, 18) . We found that the twin and IVF pregnancy rate was 4% and 0.6%, respectively. Twin pregnancy and IVF pregnancy have been reported as 20%-22% and 2.7%, respectively, in the literature (19) (20) (21) .
In our study, we evaluated patients separated into two groups as primigravid and multigravid. Our aim here was to determine the effect of first exposure to high estrogen and progesterone metabolites on the course of ICP. There was no significant difference between primigravid and multigravid patients in terms of diagnosis week of ICP, period passing until delivery, gestational age at delivery, fetal weights, transaminases, and coagulation parameters.
We determined that fetal weights were lower in early-onset ICP than late-onset ICP, although there was no difference between the two groups in terms of the mean gestational weeks at delivery. Taking into account that there was no significant difference in terms of age, hematocrit, transaminases, and coagulation parameters between the two groups, further studies should be done for the cause of the difference between the fetal weights. On the other hand, the period passing until delivery was longer in early-onset group. Because of waiting until the 37th gestational week in order to proceed with labor, it is an expected result that the period passing until delivery in early-onset ICP is longer.
When we evaluated ICP in terms of intrauterine fetal death, intrauterine fetal death rates were relatively high at 15% in old studies and 3.5% in more recent studies (22) . In a study conducted by Turunen et al., intrauterine fetal death rate was found to be 1.2%, and in our study, it was found to be 0.6%. In the same study, ICP increased the rates of induction of delivery and cesarean section. In our study, the rate of cesarean section was 75.3% (6) . When it is taken into account that ICP is not an indication for cesarean section alone, we can further say that this increase is mostly due to the cases of repeated cesareans.
In conclusion, according to our study, the fetuses of patients with ICP diagnosed at under 32 weeks have lower birth weights although they have the same gestational age as the fetuses of the patients with ICP diagnosed after 32 weeks, and ICP is encountered mostly in the spring season. Among primigravid and multigravid patients, there is no difference in terms of week of diagnosis, gestational week at delivery, fetal weights, complete blood count, transaminase levels, and coagulation parameters.
